
Indian Drugmakers Disrupt Global Weight Loss Market with Cheaper Generics
Indian pharmaceutical companies are significantly impacting the global weight loss drug market by introducing generic versions that reduce treatment costs by up to 70 percent.
3 stories found

Indian pharmaceutical companies are significantly impacting the global weight loss drug market by introducing generic versions that reduce treatment costs by up to 70 percent.

Indian pharmaceutical companies are launching cheaper generic versions of Novo Nordisk's popular weight-loss and diabetes drugs, Ozempic and Wegovy, initiating a price war in the market.
Following the expiration of Novo's patent, Indian drugmakers are set to sell a copy of the diabetes and weight-loss drug Ozempic for approximately $14 a month, significantly cheaper than the original.